These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 326965)

  • 1. Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.
    Inoue K; Kinoshita T; Okada M; Akiyama Y
    J Immunol; 1977 Jul; 119(1):65-72. PubMed ID: 326965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical studies on damages of Escherichia coli by the immune bactericidal reaction. I. Release and degradation of phospholipids from damaged bacteria.
    Inoue K; Takamizawa A; Yano K; Amano T
    Biken J; 1974 Dec; 17(4):127-34. PubMed ID: 4619009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of phospholipids from liposomal model membrane damaged by antibody and complement.
    Kinoshita T; Inoue K; Okada M; Akiyama Y
    J Immunol; 1977 Jul; 119(1):73-6. PubMed ID: 559702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.
    Giavedoni EB; Dalmasso AP
    J Immunol; 1976 Apr; 116(4):1163-9. PubMed ID: 1254965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL; Duncan RL; Morrison DC
    J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of 14C label and complement killing of Escherichia coli.
    Wilson BM; Glynn AA
    Immunology; 1975 Mar; 28(3):391-400. PubMed ID: 1092608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH; Shin ML; Abramovitz AS; Mayer MM
    J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical studies on damages of Escherichea coli by the immune bactericidal reaction. II. Release of phosphatidylethanolamine from a phospholipase A-deficient mutant of E. coli during the immune bactericidal reaction.
    Inoue K; Yano K; Amano T
    Biken J; 1974 Dec; 17(4):135-40. PubMed ID: 4619010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-mediated killing of Salmonella typhimurium and Escherichia coli mutants which share a different content of major proteins.
    Galdiero F; Sommese L; Capasso C; Galdiero M; Tufano MA
    Microbiologica; 1991 Apr; 14(2):119-30. PubMed ID: 1857264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli.
    Taylor PW; Kroll HP
    Mol Immunol; 1984 Jul; 21(7):609-20. PubMed ID: 6379418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-independent interactions between Escherichia coli J5 and human complement components.
    Betz SJ; Isliker H
    J Immunol; 1981 Nov; 127(5):1748-54. PubMed ID: 6795260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phospholipids and complementation in "Escherichia coli" K12 chl-r mutants (author's transl)].
    Azoulay E; Rivière C; Pommier J
    Ann Microbiol (Paris); 1974 Sep; 125 B(2):305-16. PubMed ID: 4617546
    [No Abstract]   [Full Text] [Related]  

  • 16. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of complement-dependent release of phospholipid from Escherichia coli.
    Wilson LA; Spitznagel JK
    Infect Immun; 1971 Jul; 4(1):23-8. PubMed ID: 5005285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange of phospholipids between Escherichia coli cells and environment.
    Galdiero F; Sommese L; Capasso C; Galdiero M; Cappello M; Tufano MA
    Microb Pathog; 1993 Feb; 14(2):85-94. PubMed ID: 8502164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid composition-dependent incorporation of multiple membrane proteins into liposomes.
    Daghastanli KR; Ferreira RB; Thedei G; Maggio B; Ciancaglini P
    Colloids Surf B Biointerfaces; 2004 Aug; 36(3-4):127-37. PubMed ID: 15276628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of phospholipid molecular species in outer and cytoplasmic membrane of Escherichia coli.
    Ishinaga M; Kanamoto R; Kito M
    J Biochem; 1979 Jul; 86(1):161-5. PubMed ID: 383707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.